Brewin Dolphin LTD Petros Pharmaceuticals, Inc. Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Nov 09, 2023
SELL
$2.87 - $4.11 $6,150 - $8,807
-2,143 Closed
0 $0
Q4 2020

Nov 09, 2023
BUY
$3.24 - $4.68 $6,943 - $10,029
2,143 New
2,143 $9.43 Million

About Petros Pharmaceuticals, Inc.

PTPI Quotes by TradingView
  • Ticker PTPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,708,000
  • Market Cap $5.38M
  • Description
  • Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for th...
More about PTPI
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email